ABTTICKER
Abbott Laboratories
Congress has disclosed 81 buys and 63 sells of ABT (Abbott Laboratories) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
81
Buy
63
Sell
+18
Net
41
Active politicians
Round-trip watch Still on the books
Members who disclosed buying ABT and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Thomas Kean | 2026-01-29 | $104.04 | $108.27 | +4.1% | ↩ near entry |
| Gilbert Cisneros | 2026-09-18 | $101.98 | $108.27 | +6.2% | ↩ near entry |
| Rohit Khanna | 2026-06-02 | $85.83 | $108.27 | +26.1% | in profit |
| Richard Dean McCormick | 2026-06-12 | $87.02 | $108.27 | +24.4% | in profit |
| Josh Gottheimer | 2025-02-13 | $126.86 | $108.27 | -14.7% | underwater |
Price as of 2026-11-02. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Health. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/E
30.05
≈ in line with
Health (median 29.7)
how it's calculated
P/E = price ÷ earnings per share
$108.27 ÷ $3.60 = 30.05
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
3.62
▼ cheaper than
Health (median 4.4)
how it's calculated
P/B = price ÷ book value per share
$108.27 ÷ $29.89 = 3.62
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
Legislation Related Legislation
Recent bills in this stock's sector (Health). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10887 | Protecting Consumer Access to Generic Drugs Act of 2026 | Health | 2026-10-22 |
| HR 10874 | Medicare Low Income Subsidy Equality Act of 2026 | Health | 2026-10-22 |
| HR 10858 | CARE for Blood Cancer Act of 2026 | Health | 2026-10-22 |
| HR 10810 | National Patient Safety Board Act of 2026 | Health | 2026-10-15 |
| HR 10824 | Stroke Education and EMS Care Improvement Act of 2026 | Health | 2026-10-15 |
146 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Gilbert Cisneros | House | BUY ◆ insider divergence · moderate | Self · 150 Main Street Trust > Bank of America | 2026-09-18 | 21 days | -2.9% | $1K–$15K 0.1% of NW |
51.5 | ↗ filing |
| Thomas Kean | House | SELL ◆ insider convergence · moderate | Self · Kean Family Partnership | 2026-09-17 | 14 days | -5.4% | $1K–$15K 0.1% of NW |
95.5 | ↗ filing |
| Richard Dean McCormick | House | SELL ◆ insider convergence · moderate | Self · Growth Partners Roth IRA | 2026-07-30 | 13 days | +5.0% | $1K–$15K 0.7% of NW |
51.2 | ↗ filing |
| Mike Kelly | House | SELL ◆ insider convergence · moderate | Spouse · Victoria Kelly Trust ICA | 2026-07-17 | 26 days | +10.2% | $1K–$15K 0.1% of NW |
99.4 | ↗ filing |
| Rick Larsen | House | SELL ◆ insider convergence · moderate | Self · Richard R Larsen IRA | 2026-07-08 | 1 days | -0.8% | $1K–$15K 0.7% of NW |
54.7 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider convergence · strong | Self · 150 Main Street Trust > Bank of America | 2026-06-16 | 16 days | +5.3% | $1K–$15K 0.1% of NW |
30.0 | ↗ filing |
| Richard Dean McCormick | House | BUY ◆ insider convergence · strong | Self · Growth Partners IRA | 2026-06-12 | 26 days | +7.9% | $1K–$15K 0.7% of NW |
48.9 | ↗ filing |
| Richard Dean McCormick | House | BUY ◆ insider convergence · strong | Self · Growth Partners Roth IRA | 2026-06-12 | 26 days | +7.9% | $1K–$15K 0.7% of NW |
48.9 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · strong | Child | 2026-06-02 | 29 days | +6.0% | $1K–$15K | 32.7 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider divergence · strong | Joint · Morgan Stanley - Select UMA Account # 1 | 2026-05-27 | 6 days | +1.5% | $1K–$15K <0.1% of NW |
19.9 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider divergence · strong | Self · 150 Main Street Trust > Bank of America | 2026-05-15 | 21 days | +7.8% | $1K–$15K 0.1% of NW |
29.4 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider divergence · strong | Joint · Merrill Lynch Tax Efficient Core | 2026-05-12 | 22 days | +3.1% | $1K–$15K <0.1% of NW |
30.3 | ↗ filing |
| Alan Armstrong | Senate | OTHER | Self | 2026-03-27 | 116 days | -2.9% | $15K–$50K | 99.6 | ↗ eFD |
| Laura Friedman | House | EXCHANGE | Self · Fidelity Brokerage Services, LLC | 2026-03-24 | 10 days | -1.1% | $1K–$15K 0.5% of NW |
85.4 | ↗ filing |
| Richard Dean McCormick | House | BUY ◆ insider convergence · strong | Self · Growth Partners IRA | 2026-03-19 | 19 days | -5.0% | $1K–$15K 0.7% of NW |
29.9 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider divergence · strong | Spouse | 2026-03-04 | 33 days | -9.5% | $1K–$15K | 33.4 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider divergence · strong | Spouse | 2026-02-27 | 6 days | -4.6% | $15K–$50K | 64.9 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · strong | Child | 2026-02-24 | 8 days | -1.3% | $15K–$50K | 54.7 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider divergence · strong | Self · 150 Main Street Trust > Bank of America | 2026-02-10 | 24 days | -2.4% | $1K–$15K 0.1% of NW |
28.4 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider convergence · strong | Spouse | 2026-02-05 | 28 days | +1.8% | $15K–$50K | 96.9 | ↗ filing |
| Thomas Kean | House | BUY ◆ insider convergence · strong | Self · Kean Family Partnership | 2026-01-29 | 7 days | +2.8% | $1K–$15K 0.1% of NW |
84.8 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider divergence · strong | Child | 2026-01-22 | 12 days | +0.4% | $15K–$50K | 30.0 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider divergence · strong | Child | 2026-01-22 | 12 days | +0.4% | $1K–$15K | 13.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · strong | Child | 2025-12-30 | 5 days | -1.3% | $1K–$15K | 13.4 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider divergence · strong | Self · 150 Main Street Trust > Bank of America | 2025-12-19 | 21 days | +0.4% | $1K–$15K 0.1% of NW |
49.6 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider divergence · strong | Joint · Chase Brokerage Account (3935) | 2025-12-18 | 18 days | +1.1% | $1K–$15K <0.1% of NW |
49.4 | ↗ filing |
| Julia Letlow | House | SELL ◆ insider divergence · strong | Self · Merrill Lynch Investment Account #025 | 2025-12-08 | 24 days | +2.6% | $1K–$15K 1.0% of NW |
60.4 | ↗ filing |
| Byron Donalds | House | SELL ◆ insider divergence · strong | Self · Moran Wealth IRA | 2025-12-04 | 28 days | -0.1% | $1K–$15K 0.3% of NW |
50.3 | ↗ filing |
| Byron Donalds | House | SELL ◆ insider divergence · strong | Spouse · Moran Wealth IRA | 2025-12-04 | 28 days | -0.1% | $1K–$15K 0.3% of NW |
50.3 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider divergence | Self · 150 Main Street Trust > Bank of America | 2025-11-18 | 24 days | -3.5% | $1K–$15K 0.1% of NW |
33.3 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider convergence | Joint · Chase Brokerage Account (3935) | 2025-11-13 | 22 days | -3.2% | $1K–$15K <0.1% of NW |
50.9 | ↗ filing |
| Richard Dean McCormick | House | BUY ◆ insider divergence | Self | 2025-11-05 | 34 days | -2.6% | $1K–$15K 0.7% of NW |
53.7 | ↗ filing |
| Rick Larsen | House | BUY ◆ insider divergence | Self · Richard R Larsen IRA | 2025-10-06 | 1 days | -0.5% | $1K–$15K 0.7% of NW |
48.9 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider convergence | Joint · Chase Brokerage Account (3935) | 2025-08-14 | 19 days | +1.7% | $1K–$15K <0.1% of NW |
82.4 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2025-08-06 | 29 days | +1.4% | $1K–$15K | 32.7 | ↗ filing |
| Thomas Kean | House | BUY ◆ insider divergence | Self · Kean Family Partnership | 2025-07-21 | 11 days | +2.3% | $1K–$15K 0.1% of NW |
82.6 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-07-18 | 20 days | +6.8% | $1K–$15K <0.1% of NW |
24.4 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider convergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-07-10 | 34 days | -2.7% | $1K–$15K 0.1% of NW |
93.8 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-06-24 | 50 days | -5.9% | $1K–$15K 0.1% of NW |
98.1 | ↗ filing |
| Jefferson Shreve | House | SELL ◆ insider convergence | Self · CRT - Standard Unit Trust | 2025-05-12 | 3 days | +1.0% | $50K–$100K <0.1% of NW |
89.3 | ↗ filing |
| Bruce Westerman | House | SELL ◆ insider convergence · moderate | Self · Fisher IRA | 2025-04-21 | 7 days | -0.3% | $1K–$15K 0.7% of NW |
48.8 | ↗ filing |
| Byron Donalds | House | BUY ◆ insider divergence · moderate | Self · Moran Wealth IRA | 2025-03-20 | 18 days | -1.5% | $1K–$15K 0.3% of NW |
67.4 | ↗ filing |
| Byron Donalds | House | BUY ◆ insider divergence · moderate | Spouse · Moran Wealth IRA | 2025-03-20 | 18 days | -1.5% | $1K–$15K 0.3% of NW |
67.4 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence · moderate | Child | 2025-03-12 | 26 days | -4.2% | $1K–$15K | 12.3 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-03-06 | 29 days | -7.9% | $1K–$15K <0.1% of NW |
6.2 | ↗ filing |
| Bruce Westerman | House | BUY ◆ insider divergence · moderate | Self · Fisher IRA | 2025-03-03 | 14 days | -9.0% | $1K–$15K 0.7% of NW |
84.8 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-02-13 | 20 days | +4.5% | $1K–$15K <0.1% of NW |
7.3 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-01-29 | 8 days | +0.3% | $1K–$15K <0.1% of NW |
7.8 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-01-28 | 9 days | +0.7% | $1K–$15K <0.1% of NW |
9.5 | ↗ filing |
| Jared Moskowitz | House | SELL ◆ insider convergence · moderate | Self · Morgan Stanley Active Assets (1) | 2025-01-15 | 16 days | +15.1% | $1K–$15K 0.3% of NW |
25.2 | ↗ filing |
| Jared Moskowitz | House | SELL ◆ insider convergence · moderate | Child · Morgan Stanley Active Assets (5) | 2025-01-15 | 16 days | +15.1% | $1K–$15K 0.3% of NW |
25.2 | ↗ filing |
| Jared Moskowitz | House | SELL ◆ insider convergence · moderate | Child · Morgan Stanley Active Assets (6) | 2025-01-15 | 16 days | +15.1% | $1K–$15K 0.3% of NW |
25.2 | ↗ filing |
| Emily Randall | House | SELL ◆ insider convergence · moderate | Spouse · Garret D. Leahey 2019 Irrevocable F/B/O Alison Leahey | 2025-01-06 | 35 days | +16.8% | $1K–$15K | 99.7 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2025-01-02 | 33 days | +14.4% | $1K–$15K | 24.8 | ↗ filing |
| Thomas Kean | House | BUY ◆ insider divergence · moderate | Self · Kean Family Partnership | 2024-12-16 | 21 days | +0.4% | $1K–$15K 0.1% of NW |
89.4 | ↗ filing |
| Julia Letlow | House | BUY ◆ insider divergence | Self · Merrill Lynch Investment Account #025 | 2024-10-23 | 292 days | +13.9% | $1K–$15K 1.0% of NW |
66.0 | ↗ filing |
| John James | House | SELL ◆ insider convergence | Self · John A. James Children’s Trust | 2024-09-04 | 1 days | -1.1% | $1K–$15K <0.1% of NW |
84.6 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-08-19 | 18 days | +1.0% | $1K–$15K <0.1% of NW |
11.7 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-07-29 | 14 days | — | $1K–$15K <0.1% of NW |
50.2 | ↗ filing |
| Thomas Kean | House | BUY ◆ insider divergence | Self · Kean Family Partnership | 2024-07-23 | 13 days | — | $1K–$15K 0.1% of NW |
99.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-07-18 | 18 days | — | $1K–$15K | 51.0 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence | Self · Morgan Stanley Active Assets (1) | 2024-07-05 | 26 days | — | $1K–$15K 0.3% of NW |
63.0 | ↗ filing |
| Kathy Manning | House | BUY ◆ insider divergence | Spouse · MV Capital - GST Exempt Trust #2 | 2024-07-02 | 43 days | — | $1K–$15K 0.1% of NW |
32.7 | ↗ filing |
| Kathy Manning | House | BUY ◆ insider divergence | Spouse · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2024-07-02 | 43 days | — | $1K–$15K 0.1% of NW |
32.7 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-05-29 | 6 days | — | $1K–$15K | 5.5 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-05-20 | 15 days | — | $1K–$15K | 6.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2024-04-26 | 5 days | — | $1K–$15K | 8.6 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2024-04-18 | 13 days | — | $1K–$15K | 10.6 | ↗ filing |
| Jared Moskowitz | House | SELL ◆ insider convergence · moderate | Self · Morgan Stanley Active Assets (1) | 2024-02-13 | 181 days | — | $1K–$15K 0.3% of NW |
67.2 | ↗ filing |
| Kathy Manning | House | SELL ◆ insider convergence · moderate | Spouse · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2024-01-23 | 10 days | — | $1K–$15K 0.1% of NW |
9.6 | ↗ filing |
| Kathy Manning | House | SELL ◆ insider convergence · moderate | Spouse · MV Capital - GST Exempt Trust #2 | 2024-01-23 | 10 days | — | $1K–$15K 0.1% of NW |
9.6 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2023-12-05 | 30 days | — | $1K–$15K | 26.5 | ↗ filing |
| John Curtis | House | SELL ◆ insider convergence | Joint · Northwestern Mutual - Joint | 2023-12-04 | 0 days | — | $1K–$15K | 26.5 | ↗ filing |
| John James | House | BUY ◆ insider divergence | Self · John A. James Children’s Trust | 2023-11-10 | 277 days | — | $1K–$15K <0.1% of NW |
98.8 | ↗ filing |
| Greg Stanton | House | SELL ◆ insider convergence | Spouse | 2023-10-24 | 2 days | — | $1K–$15K 0.5% of NW |
40.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-10-02 | 35 days | — | $1K–$15K | 50.5 | ↗ filing |
| Greg Stanton | House | BUY ◆ insider divergence | Spouse | 2023-09-26 | 25 days | — | $1K–$15K 0.5% of NW |
93.1 | ↗ filing |
| John Curtis | House | BUY ◆ insider divergence | Joint · Northwestern Mutual - Joint | 2023-09-13 | 19 days | — | $1K–$15K | 50.5 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-08-04 | 32 days | — | $1K–$15K | 40.4 | ↗ filing |
| Kathy Manning | House | BUY ◆ insider divergence · moderate | Self · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2023-04-28 | 4 days | — | $1K–$15K 0.1% of NW |
10.6 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2023-03-24 | 10 days | — | $1K–$15K | 86.8 | ↗ filing |
| Richard Dean McCormick | House | BUY ◆ insider divergence · moderate | Self · Growth Partners Roth IRA | 2023-03-15 | 26 days | — | $1K–$15K 0.7% of NW |
86.8 | ↗ filing |
| Daniel Goldman | House | SELL ◆ insider convergence · moderate | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-03-06 | 28 days | — | $50K–$100K <0.1% of NW |
94.3 | ↗ filing |
| Rick Larsen | House | SELL ◆ insider convergence · moderate | Self · Richard R Larsen IRA > Ameriprise SPS Managed Account | 2023-01-06 | 132 days | — | $1K–$15K 0.7% of NW |
75.9 | ↗ filing |
| John Curtis | House | SELL | Joint · Northwestern Mutual - Joint | 2022-10-21 | 11 days | — | $1K–$15K | 52.4 | ↗ filing |
| David McKinley | House | SELL | Self · IRA's > IRA- Spouse | 2022-09-21 | 9 days | — | $1K–$15K | 19.6 | ↗ filing |
| Kathy Manning | House | BUY | Spouse · MV Capital - GST Exempt Trust #2 | 2022-07-27 | 6 days | — | $1K–$15K 0.1% of NW |
52.4 | ↗ filing |
| Kathy Manning | House | BUY | Self · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2022-07-27 | 6 days | — | $1K–$15K 0.1% of NW |
52.4 | ↗ filing |
| Kathy Manning | House | BUY | Spouse · The 2011 Randall R. Kaplan Living Trust > MV Capital - Brokerage #2 | 2022-07-27 | 6 days | — | $1K–$15K 0.1% of NW |
52.4 | ↗ filing |
| Robert Wittman | House | BUY | Self · Morgan Stanley | 2022-07-15 | 4 days | — | $1K–$15K 0.2% of NW |
19.6 | ↗ filing |
| Kathy Manning | House | BUY | Spouse · The 2011 Randall R. Kaplan Living Trust > MV Capital - Brokerage #3 | 2022-07-15 | 18 days | — | $1K–$15K 0.1% of NW |
86.8 | ↗ filing |
| Robert Wittman | House | SELL | Self · Morgan Stanley | 2022-06-16 | 5 days | — | $1K–$15K 0.2% of NW |
15.7 | ↗ filing |
| Robert Wittman | House | BUY ◆ insider divergence | Self | 2022-04-19 | 2 days | — | $1K–$15K 0.2% of NW |
22.3 | ↗ filing |
| Robert Wittman | House | SELL ◆ insider convergence | Self · Morgan Stanley | 2022-03-15 | 2 days | — | $1K–$15K 0.2% of NW |
40.4 | ↗ filing |
| Michael Burgess | House | SELL ◆ insider convergence | Self | 2022-01-07 | 4 days | — | $1K–$15K 0.2% of NW |
40.4 | ↗ filing |
| Michael Burgess | House | BUY | Self | 2021-12-02 | 4 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
| Kim Schrier | House | SELL | Joint | 2021-10-28 | 1 days | — | $1K–$15K <0.1% of NW |
99.0 | ↗ filing |
| Carol Devine Miller | House | BUY | Spouse | 2021-03-04 | 28 days | — | $1K–$15K <0.1% of NW |
98.8 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2021-01-05 | 34 days | — | $1K–$15K <0.1% of NW |
10.6 | ↗ filing |
| Dean Phillips | House | BUY | Self · Trust 1 | 2021-01-05 | 34 days | — | $1K–$15K <0.1% of NW |
10.6 | ↗ filing |
| Katherine Clark | House | SELL | Spouse | 2020-11-10 | 48 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Katherine Clark | House | SELL | Spouse | 2020-11-05 | 53 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Katherine Clark | House | BUY | Spouse | 2020-10-22 | 36 days | — | $1K–$15K 0.1% of NW |
93.1 | ↗ filing |
| Michael Conaway | House | BUY | Self | 2020-09-28 | 4 days | — | $15K–$50K | 54.7 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2020-09-23 | 14 days | — | $1K–$15K <0.1% of NW |
33.6 | ↗ filing |
| David McKinley | House | SELL | Joint | 2020-08-28 | 3 days | — | $1K–$15K | 26.5 | ↗ filing |
| Joe Courtney | House | SELL | Spouse | 2020-08-07 | 0 days | — | $1K–$15K 0.6% of NW |
96.2 | ↗ filing |
| David McKinley | House | BUY | Self | 2020-04-30 | 0 days | — | $1K–$15K | 31.8 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2020-04-02 | 34 days | — | $1K–$15K <0.1% of NW |
58.5 | ↗ filing |
| John Curtis | House | BUY | Self | 2020-03-27 | 0 days | — | $1K–$15K | 93.1 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-03-18 | 28 days | — | $1K–$15K 0.1% of NW |
93.1 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2020-03-13 | 25 days | — | $1K–$15K <0.1% of NW |
31.8 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2020-02-28 | 7 days | — | $1K–$15K <0.1% of NW |
59.5 | ↗ filing |
| Mikie Sherrill | House | SELL | Self | 2020-02-20 | 12 days | — | $1K–$15K 0.1% of NW |
86.8 | ↗ filing |
| Joe Courtney | House | BUY | Spouse | 2019-12-31 | 0 days | — | $1K–$15K 0.6% of NW |
98.8 | ↗ filing |
| Richard Allen | House | BUY | Spouse · LIVTR | 2019-09-27 | 8 days | — | $15K–$50K 1.4% of NW |
97.2 | ↗ filing |
| Richard Allen | House | BUY | Self · R.W. Allen & Associates, Inc. > RWA&A - Securities | 2019-09-13 | 22 days | — | $15K–$50K 1.4% of NW |
99.5 | ↗ filing |
| Elizabeth Fletcher | House | SELL | Spouse | 2019-07-09 | 3 days | — | $1K–$15K 0.2% of NW |
98.8 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2019-06-20 | 20 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2019-03-15 | 20 days | — | $1K–$15K <0.1% of NW |
40.4 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2019-02-27 | 23 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| David McKinley | House | BUY | Self | 2018-12-20 | 11 days | — | $1K–$15K | 75.9 | ↗ filing |
| David McKinley | House | BUY | Joint | 2018-12-20 | 11 days | — | $15K–$50K | 90.9 | ↗ filing |
| Pete Sessions | House | BUY | Spouse | 2018-05-02 | 2 days | — | $1K–$15K 0.2% of NW |
94.6 | ↗ filing |
| Kenneth Buck | House | SELL | Self | 2017-11-07 | 6 days | — | $1K–$15K 3.9% of NW 🔥 |
52.4 | ↗ filing |
| Kenneth Buck | House | BUY | Self | 2017-10-27 | 5 days | — | $1K–$15K 3.9% of NW 🔥 |
75.9 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2017-10-11 | 0 days | — | $1K–$15K 0.3% of NW |
26.5 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2017-10-04 | 0 days | — | $1K–$15K 0.3% of NW |
22.3 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2017-07-06 | 0 days | — | $1K–$15K 0.3% of NW |
40.4 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2017-04-19 | 5 days | — | $15K–$50K | 48.0 | ↗ filing |
| Virginia Foxx | House | SELL | Joint | 2016-11-10 | 0 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
| Michael Conaway | House | BUY | Spouse | 2016-09-12 | 3 days | — | $15K–$50K | 56.6 | ↗ filing |
| Debbie Dingell | House | BUY | Spouse | 2016-06-01 | 5 days | — | $1K–$15K 0.1% of NW |
99.3 | ↗ filing |
| Thomas Rooney | House | BUY | Self | 2016-06-01 | 30 days | — | $1K–$15K | 86.8 | ↗ filing |
| Virginia Foxx | House | BUY | Joint | 2016-01-28 | 0 days | — | $1K–$15K 0.2% of NW |
84.3 | ↗ filing |
| Virginia Foxx | House | BUY | Joint | 2016-01-22 | 0 days | — | $1K–$15K 0.2% of NW |
88.5 | ↗ filing |
| Robert Wittman | House | SELL | Self | 2015-09-23 | 5 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
| Virginia Foxx | House | SELL | Child | 2015-08-21 | 0 days | — | $15K–$50K 0.7% of NW |
97.2 | ↗ filing |
| Frank LoBiondo | House | BUY | Spouse | 2015-07-30 | 356 days | — | $1K–$15K | 86.8 | ↗ filing |
| Pete Sessions | House | BUY | Spouse | 2015-07-27 | 0 days | — | $15K–$50K 0.9% of NW |
99.8 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2015-05-27 | 0 days | — | $1K–$15K 0.3% of NW |
75.9 | ↗ filing |
| Virginia Foxx | House | BUY | Joint | 2015-03-18 | 0 days | — | $15K–$50K 0.7% of NW |
99.5 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2015-02-09 | 3 days | — | $1K–$15K | 75.9 | ↗ filing |
| Bill Flores | House | SELL | Self | 2014-06-10 | 27 days | — | $15K–$50K | 48.0 | ↗ filing |
| Bill Flores | House | BUY | Self | 2014-02-05 | 27 days | — | $1K–$15K | 40.4 | ↗ filing |
| Bill Flores | House | BUY | Self | 2013-12-30 | 4 days | — | $15K–$50K | 90.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in ABT — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
37
Congress trades with insider convergence
48
…with insider divergence
79
Insider open-market trades
Of the congressional trades in ABT, 37 coincided with corporate insiders moving the same way within 60 days, and 48 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-09-02 | MCCOY JOHN A. JR. | Other | SELL | $3K | ↗ EDGAR |
| 2026-08-25 | Ford Robert B | C-suite | SELL | $25.3M | ↗ EDGAR |
| 2026-08-25 | Ford Robert B | C-suite | SELL | $20.9M | ↗ EDGAR |
| 2026-08-11 | Morrone Louis H. | Other | SELL | $643K | ↗ EDGAR |
| 2026-05-07 | Stratton John G | Director | BUY | $174K | ↗ EDGAR |
| 2026-04-27 | STARKS DANIEL J | Director | BUY | $927K | ↗ EDGAR |
| 2026-04-23 | Boudreau Philip P | C-suite | BUY | $201K | ↗ EDGAR |
| 2026-03-02 | Salvadori Daniel Gesua Sive | C-suite | SELL | $102K | ↗ EDGAR |
| 2026-03-02 | MCCOY JOHN A. JR. | Other | SELL | $68K | ↗ EDGAR |
| 2026-03-02 | Moreland Mary K | Other | SELL | $71K | ↗ EDGAR |
| 2026-03-02 | Morrone Louis H. | Other | SELL | $132K | ↗ EDGAR |
| 2026-03-02 | Shroff Eric | Other | SELL | $82K | ↗ EDGAR |
| 2026-03-02 | Cushman Elizabeth C. | Other | SELL | $30K | ↗ EDGAR |
| 2026-02-04 | STARKS DANIEL J | Director | BUY | $542K | ↗ EDGAR |
| 2026-02-04 | STARKS DANIEL J | Director | BUY | $545K | ↗ EDGAR |
| 2026-01-23 | Ford Robert B | C-suite | BUY | $2.0M | ↗ EDGAR |
| 2025-11-25 | Shroff Eric | Other | SELL | $203K | ↗ EDGAR |
| 2025-08-08 | Boudreau Philip P | C-suite | SELL | $747K | ↗ EDGAR |
| 2025-04-30 | Blount Sally E. | Director | SELL | $337K | ↗ EDGAR |
| 2025-03-07 | Earnhardt Lisa D | C-suite | SELL | $27K | ↗ EDGAR |
| 2025-03-06 | Earnhardt Lisa D | C-suite | SELL | $12.2M | ↗ EDGAR |
| 2025-03-03 | MCCOY JOHN A. JR. | Other | SELL | $78K | ↗ EDGAR |
| 2025-03-03 | Moreland Mary K | Other | SELL | $109K | ↗ EDGAR |
| 2025-03-03 | Morrone Louis H. | Other | SELL | $154K | ↗ EDGAR |
| 2025-03-03 | Shroff Eric | Other | SELL | $78K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| Congress | 2026-09-18 | Gilbert Cisneros | BUY | $1K–$15K |
| Congress | 2026-09-17 | Thomas Kean | SELL | $1K–$15K |
| ◆ insider | 2026-09-02 | MCCOY JOHN A. JR. Other | SELL | $3K |
| ◆ insider | 2026-08-25 | Ford Robert B C-suite | SELL | $25.3M |
| ◆ insider | 2026-08-25 | Ford Robert B C-suite | SELL | $20.9M |
| ◆ insider | 2026-08-11 | Morrone Louis H. Other | SELL | $643K |
| Congress | 2026-07-30 | Richard Dean McCormick | SELL | $1K–$15K |
| Congress | 2026-07-17 | Mike Kelly | SELL | $1K–$15K |
| Congress | 2026-07-08 | Rick Larsen | SELL | $1K–$15K |
| Congress | 2026-06-16 | Gilbert Cisneros | BUY | $1K–$15K |
| Congress | 2026-06-12 | Richard Dean McCormick | BUY | $1K–$15K |
| Congress | 2026-06-12 | Richard Dean McCormick | BUY | $1K–$15K |
| Congress | 2026-06-02 | Rohit Khanna | BUY | $1K–$15K |
| Congress | 2026-05-27 | Josh Gottheimer | SELL | $1K–$15K |
| Congress | 2026-05-15 | Gilbert Cisneros | SELL | $1K–$15K |
| Congress | 2026-05-12 | Julie Johnson | SELL | $1K–$15K |
| ◆ insider | 2026-05-07 | Stratton John G Director | BUY | $174K |
| ◆ insider | 2026-04-27 | STARKS DANIEL J Director | BUY | $927K |
| ◆ insider | 2026-04-23 | Boudreau Philip P C-suite | BUY | $201K |
| Congress | 2026-03-27 | Alan Armstrong | OTHER | $15K–$50K |
| Congress | 2026-03-24 | Laura Friedman | EXCHANGE | $1K–$15K |
| Congress | 2026-03-19 | Richard Dean McCormick | BUY | $1K–$15K |
| Congress | 2026-03-04 | Michael McCaul | SELL | $1K–$15K |
| ◆ insider | 2026-03-02 | Salvadori Daniel Gesua Sive C-suite | SELL | $102K |
FAQ Common questions
How much has Congress traded ABT?
81 disclosed buys and 63 sells of ABT (Abbott Laboratories) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade ABT?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.